SynthesisClinical drug investigation2019

Long-Acting Injectable (LAI) Aripiprazole Formulations in the Treatment of Schizophrenia and Bipolar Disorder: a Systematic Review.

Chiara Rapinesi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.